Monoamine oxidase inhibitors (MAOI) have already been identified to prolong and enhance the results of dimethyltryptamine (copyright) and one particular research assumed which the effect on psilocybin could be similar because it can be a structural analogue of copyright.[145] Having said that, only a little portion of psilocin seems for being metab